title: Assessment of tumor growth inhibition metrics to predict overall survival.
authors: Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, France.
authors: L
authors: L
authors: Claret
authors: Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, France.
authors: R
authors: R
authors: Bruno
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male